Oramed Pharma (ORMP)

$2.39 0.08 (3.24%)

15:14 EDT ORMP Stock Quote Delayed 30 Minutes

ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q1 2024

By InvestorPlace Earnings May 9, 2024

ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.

ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023

Why Is Oramed (ORMP) Stock Down 75% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

More Articles

Volume:

Previous Close -

Market Cap 77.71M

PE Ratio 21.73

EPS 0.11

Volume (Avg. Vol.) 113,472

Day's Range $2.35 - $2.44

52-Week Range $1.67 - $5.25

Dividend & Yield N/A (N/A)

ORMP Stock Predictions, Articles, and Oramed Pharma News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Nov 23, 2021

Good morning, investors! We're getting right back to the grind today with a dive into the biggest pre-market stock movers for Tuesday.

7 Top-Rated Pharmaceutical Stocks To Invest in for October

By Louis Navellier and the InvestorPlace Research Staff Oct 4, 2021

It's a great time to look beyond the big name pharmaceutical stocks and look for great niche players with big futures.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer May 11, 2021

InvestorPlace is starting the day off right by checking out the biggest pre-market stock movers, including the winners and losers.

Oramed's Chinese partner HTIT completes phase 3 oral insulin trial (NASDAQ:ORMP)

From Seeking Alpha May 15, 2023

Oramed Pharmaceuticals (ORMP) has announced the successful completion of Phase 3 trials for oral insulin in type 2 diabetes in China by its strategic partner, Hefei Tianhui...

Investing millions, Ben Shapiro joins board of Oramed Pharmaceuticals

From Seeking Alpha May 3, 2023

Conservative political commentator and entrepreneur, Ben Shapiro, has taken a $4.7M stake in struggling Israeli pharmaceutical company Oramed Pharmaceuticals. Read more here.

Conservative Pundit Ben Shapiro Invests $4.7 Million in Israeli Drug Company

From Bloomberg May 2, 2023

Right-wing media entrepreneur Ben Shapiro has taken a $4.7 million stake in a struggling Israeli pharmaceutical company and joined the board.

Hot Stocks: CTSH rises on guidance; LOGI slumps; CAT hits 52-week high; ORMP plunges 76%

From Seeking Alpha Jan 13, 2023

CAT set a 52-week high. CTSH rose on guidance and a leadership change. LOGI falls on a weak forecast. ORMP plunged 76% on clinical data.

Why Oramed Pharmaceuticals Stock Is Crashing Today

From The Motley Fool Jan 12, 2023

The company's lead pipeline candidate is still being evaluated as a potential treatment for NASH after a major flop in treating type 2 diabetes.

Oramed Pharma Up After Positive Clinical Data

From TipRanks Nov 18, 2022

Shares of Oramed Pharmaceuticals (NASDAQ: ORMP) were on an upswing in pre-market trading on Friday as the clinical-stage pharmaceutical company announced additional...

ADVERTISEMENT